![](https://static.biospace.com/dims4/default/0b20b54/2147483647/strip/true/crop/360x180+0+0/resize/200x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F88%2F9c%2F447482e9493e80771cf1632b448f%2Fshepherd-therapeutics.png)
Shepherd Therapeutics
NEWS
Biopharmaceutical companies are focusing their drugs for smaller and smaller and more clearly delineated patient populations. No longer is a drug for lung cancer or even non-small cell lung cancer, but a much smaller segment.
There are many unusual things about Shepherd Therapeutics, but one of them is its origin.
BioSpace is proud to present its NextGen “Class of 2018,” a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.
IN THE PRESS
JOBS